Pfizer-BioNTech COVID Vaccine 90.7% Effective in Children 5-11: Shots

108

Pharmacist LaChandra McGowan prepares a dose of the Pfizer COVID-19 vaccine at a DePaul Community Health-operated clinic in New Orleans in August. Soon, children ages 5-11 could be eligible for Pfizer shots.

Mario Tama / Getty Images


Hide caption

Toggle caption

Mario Tama / Getty Images


Pharmacist LaChandra McGowan prepares a dose of the Pfizer COVID-19 vaccine at a DePaul Community Health-operated clinic in New Orleans in August. Soon, children ages 5-11 could be eligible for Pfizer shots.

Mario Tama / Getty Images

Pfizer and its partner BioNTech say their data supports the approval of their COVID-19 vaccine in children aged 5-11.

The Food and Drug Administration published the briefing document of the companies Friday morning as a prelude to a specialist consultant meeting of the agency planned for Tuesday.

The companies studied a vaccine dose of 10 micrograms in children aged 5 to 11 years, a third of the dose used for adults and older children. The lower dose was chosen to minimize side effects and because it still elicits a strong immune response, the companies said.

In the main clinical study conducted by the companies, the vaccine appeared to be greater than 90% against symptomatic COVID-19. to be effective

No new security issues were identified in the companies’ studies. No cases of heart inflammation were observed in the main study, but only a few thousand children were included in the study, so a rare problem would not necessarily be detected.

The antibody response to the vaccine was similar to that seen in subjects aged 16-25 years.

The FDA is preparing its own analysis, which is expected to be published on Friday.

Thank You For Reading!

Reference: www.npr.org

Leave A Reply

Your email address will not be published.

Subscribe to our newsletter
Subscribe to our newsletter
Sign up here to get the latest health and diet news, updates and special offers delivered directly to your inbox.
You can unsubscribe at any time

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More